Sunday, December 15, 2019

 


Organigram Holdings Inc
(TSX-V: OGI.VN) Add to Watchlist
$6.850
-0.030 (-0.44%)
as of Aug 21, 2019

Last 6.850
Change -0.030 (-0.44%)
Open 6.880
Prev. Close 6.880
Today's Range
6.730 6.960
52wk Range
4.110 11.300
Volume 392,662
Avg Volume 538,079

Recent Headlines
For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to expedite the development and review of drugs--given out only for therapies  (full story)
BOSS.CN: 0.230 (-0.010), BOSQF: 0.1771 (-0.0029), HEXO: 2.24 (+0.01), HEXO.TO: 2.95 (+0.02), TRUL.CN: 15.920 (-0.020), TCNNF: 12.0900 (+0.0328), TGOD.TO: 0.83 (+0.01)
International support for CBD has been explosive. At the moment, one in seven Americans say they personally use cannabidiol-based products, says a recent Gallup poll, which has only proliferated since the passage of the U.S. Farm Bill. However, those numbers are likely to increase as more CBD makes  (full story)
CBDN.CN: 0.390 (-0.050), OGI.VN: 6.850 (-0.030), OGI: 2.59 (+0.02), ZBISF: 0.1440 (-0.0035), ZENA.TO: 0.20 (unch), KSHB: 1.5900 (-0.0300)
Cannabis growth is expected to be incredibly explosive. All thanks to incredible demand from consumers. In the U.S. alone, 61% of Americans support the legalization of cannabis, according to the General Social Survey conducted by NORC at the University of Chicago. That's up from just 57% in 2016. Ev  (full story)
OGRMF: 8.3500 (+0.3700), VFRM: 1.1850 (-0.0750), APHA: 5.50 (+0.23), APHA.TO: 7.26 (+0.32), GTII.CN: 10.850 (-0.020), GTBIF: 8.1966 (-0.0834), OGI.VN: 6.850 (-0.030)
While the cannabis industry was picking up steam, companies grappled to capture the attention of consumers. Specifically, in the U.S. and Canada, federal regulators provided limited amounts of operation licenses, meaning companies applying for licenses were aggressively competing against one another  (full story)
OGRMF: 8.3500 (+0.3700), CRFTF: 0.0645 (-0.0044), CRFT.CN: 0.085 (-0.010), CRON: 7.28 (-0.02), CRON.TO: 9.61 (-0.02), OGI: 2.59 (+0.02)
CBD retail sales in the U.S. are expected to soar 133% this year $1 billion, says the 2019 Hemp & CBD Industry Factbook. By 2024, sales could balloon to $10 billion. Helping to drive those potential sales are retailers that are struggling to keep supplies on the shelves. To date, Neiman Marcus, S  (full story)
OGRMF: 8.3500 (+0.3700), VSI: 6.52 (+0.02), BOSS.CN: 0.230 (-0.010), BOSQF: 0.1771 (-0.0029), APHA: 5.50 (+0.23), APHA.TO: 7.26 (+0.32)
Performance Comparison
Name Today 3-Month 1-Year
OGI.VN -0.44% -30.24% +28.52%
$TXCX +0.33% +3.87% +15.27%
$TXCI +0.25% +3.82% +14.56%
DJIA +0.01% +7.38% +14.38%
S&P 500 +0.01% +8.87% +19.55%

Key Statistics
Annual EPS 0.232
Dividend & Yield -- (--)
P/E Ratio 29.526
Market Capitalization, $K 1,069,771
Weighted Alpha -8.80
Standard Deviation -0.17
Profit Margin 0.46%
Beta 3.966

Growth Rates
YTD +41.53%
1-Year +15.51%
3-Year +392.81%
5-Year +204.44%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.